Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Healthy Sales Growth Make Banco Santander (SAN) a Buy

By Portfolio Grader
Banco Santander SA (NYSE:SAN) is ranked as a Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking SAN has had from Portfolio Grader for the last month.

Toronto-Dominion Bank (TD) a Buy on Healthy Earnings Growth

By Portfolio Grader
Toronto-Dominion Bank (NYSE:TD) is one of the 761 companies in the GICS Financials sector, and a constituent of the 342 company Banks GICS industry group within this sector. TD's market value is $107.9 billion which places it in the top 10% of its industry group. The ranking for TD by Portfolio Grader places it 86 among the 342 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 203 among the 761 companies in the sector, and number 1,297 in the nearly 5,000 company Portfolio Grader universe.

Fewer Negatives Upgrade of Medtronic (MDT) to Hold

By Portfolio Grader
The current recommendation of Hold for Medtronic Plc (NYSE:MDT) is derived using Louis Navellier's approach to investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Royal Bank of Canada’s (RY) Robust Quant Score Make it a Buy

By Portfolio Grader
Royal Bank of Canada (NYSE:RY) is ranked as a Buy using Louis Navellier's investing system and his Portfolio Grader stock evaluator. RY has maintained this ranking for 5 months.

Vapid Quant Score Hurt Citigroup (C) Rating

By Portfolio Grader
Citigroup Inc (NYSE:C) is ranked as a Hold using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. C has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold.

HSBC Holdings plc Sponsored ADR’s (HSBC) Healthy Earnings Visibility Keep it a Buy

By Portfolio Grader
HSBC Holdings plc Sponsored ADR (NYSE:HSBC) is classified as a member of the 342 company Banks GICS industry group, which is part of the 761 company GICS Financials sector. HSBC's market value is $196.8 billion which places it in the top decile in its industry group. Currently, the stock's Portfolio Grader ranking places it 72 among the 342 companies in this industry group, giving it a well above-average position; in the top quartile of the sector with a ranking of 177 among the 761 companies in the sector, and number 1,138 in the nearly 5,000 company Portfolio Grader universe.

Industry Group Rank Make Wells Fargo & Co (WFC) a Sell

By Portfolio Grader
Currently, Wells Fargo & Co (NYSE:WFC) has a Sell using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methods. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Sales Growth Limit Bank of America (BAC) Rating

By Portfolio Grader
Bank of America Corp (NYSE:BAC) is ranked as a Hold using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. BAC has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold.

Quant Score Make JPMorgan Chase & Co (JPM) a Buy

By Portfolio Grader
JPMorgan Chase & Co (NYSE:JPM) is a member of the 342 company Banks GICS industry group, which is a segment of the 761 company GICS Financials sector. JPM has a market value of $341.1 billion which is in the top 10% of its industry group. Portfolio Grader's current ranking for JPM puts it 96 among the 342 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 231 among the 761 companies in the sector, and number 1,484 in the nearly 5,000 company Portfolio Grader universe.

Berkshire Hathaway Energy (BRK.B) a Hold on Vapid Sales Growth

By Portfolio Grader
The current recommendation of Hold for Berkshire Hathaway Energy Co (NYSE:BRK.B) is derived using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

Pallid Earnings Visibility Restrict Banco Santander Brasil (BSBR) Rating

By Portfolio Grader
The current recommendation of Hold for Banco Santander Brasil SA (NYSE:BSBR) is computed using the system for investing of Louis Navellier and his Portfolio Grader stock evaluator. BSBR has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold.

Alphabet Inc Still Is an Incredible Buy Even North of $1,000

By Chris Lau, InvestorPlace Contributor
Alphabet continues to grow its businesses at an astonishing rate. This is sustainable, so long as users keep coming back to Google on mobile

GoPro Inc Could See a Brief 35% Upside, Here’s When to Buy and Sell

By Lawrence Meyers, InvestorPlace Contributor
GPRO stock is only good for a trade.

Giving Tuesday 2017: How Many Companies Match Donations?

By Karl Utermohlen, InvestorPlace Writer
One of the largest philanthropic movements in recent years is Giving Tuesday, which is celebrated by at least 71 countries around the world.

Vertex Pharmaceuticals (VRTX) a Buy on Solid Sales Growth

By Portfolio Grader
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is ranked as a Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking VRTX has had from Portfolio Grader for 4 months.

Quant Score Make Cellect Biotechnology (APOP) a Buy

By Portfolio Grader
Cellect Biotechnology Ltd (NULL:APOP) is ranked as a Buy using Louis Navellier's investing system and his Portfolio Grader stock evaluator. APOP has maintained this ranking for 4 months.

Gap Inc (GPS) Stock Hits 52-Week High on Winning Black Friday Weekend

By Karl Utermohlen, InvestorPlace Writer
Gap (GPS) has had a strong beginning to the week as the stock hit a 52-week high on Monday morning, as it's now selling for $30.10 a share.

Regeneron Pharmaceuticals (REGN) a Hold on Uninspiring Industry Group Rank

By Portfolio Grader
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is ranked as a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing approach. This represents no change from the previous week and is the same ranking REGN has had from Portfolio Grader for 5 months.

MLP & Strategic Equity Fund (MTP) a Sell on Flopping Earnings Visibility

By Portfolio Grader
MLP & Strategic Equity Fund (NASDAQ:MTP) is classified as a component of the 349 company Biotechnology GICS industry group, which is a segment of the 781 company GICS Health Care sector. The market value of MTP is $41.5 billion which falls in the top decile in its industry group. The stock's current Portfolio Grader ranking places it 266 among the 349 companies in this industry group, a spot that is well below-average; squarely in the bottom quartile of the sector with a ranking of 618 among the 781 companies in the sector, and number 3,808 in the nearly 5,000 company Portfolio Grader universe.
Load More Articles